Mallinckrodt And Endo Shareholders Approve Merger
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 14 2025
0mins
Should l Buy ?
Source: NASDAQ.COM
Merger Approval: Mallinckrodt plc and Endo, Inc. have received shareholder approvals for their merger, which is a stock-and-cash transaction aimed at creating a global pharmaceutical leader.
Next Steps: The companies will seek court confirmation of the merger scheme from the Irish High Court, with a hearing expected in July, aiming to finalize the merger shortly after.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
